April 18, 2025 05:17 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
No change in 'waqf by user' for now till next hearing: Supreme Court to Centre | Supreme Court rules Bengal govt teachers 'not identified as tainted' in SSC scam can continue till fresh appointments | 'Yogi sabse bada bhogi hai': Mamata Banerjee slams Uttar Pradesh CM over Murshidabad riots remark | Uttar Pradesh: 11-year-old speech and hearing impaired girl brutally raped, accused nabbed | US Vice President JD Vance, his family to visit India next week; meet PM Modi | Karnataka Governor sends bill providing 4 pct reservation to Muslims in govt contracts to President | Supreme Court considers issuing interim stay on 3 points of Waqf law, Centre urges for more time to explain | Amid clash with Guv, MK Stalin forms panel to maintain Tamil Nadu's autonomy | 'I have nothing to hide': Robert Vadra reaches ED office on second summons over Haryana land deal case | 'What kind of a language is this?': Opposition slams Modi's 'young Muslims repair punctures' remark over Waqf Act
Covid-19
Image Credit: UNI

India reports 3,303 new Covid-19 cases in 24 hours

| @indiablooms | Apr 28, 2022, at 04:30 pm

New Delhi/IBNS: India reported 3,303 new Covid-19 cases while the toll went up by 39 in the last 24 hours, the Union Health Ministry said on Thursday.

In the same span of time, 2,563 Covid-19 patients have recovered.

The active caseload, which now forms 0.04% of the total cases, currently stands at 16,980.

In a coronavirus review meeting with the Chief Ministers of the country, Prime Minister Narendra Modi on Thursday said the coronavirus challenge has not yet been surpassed.

"Despite managing the Covid crisis well as compared to other countries, we can see an uptick in cases in states now. We have to stay alert," the Prime Minister said.

Under the national vaccination drive, 188.40 crore anti-Covid-19 vaccine doses have so far been administered in the country.

After Biological E's Corbevax, India's drug regulator (DCGI) on Wednesday approved Bharat Biotech's Covaxin as the second anti-Covid vaccine for children aged 5-12.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu